IntelGenx Technologies Corp. is a Canada-based drug delivery company focusing on the development of novel, orally administered drug delivery products based on its proprietary oral drug delivery technologies. The Company has positioned themselves as a provider of product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets. The Company’s products under development focus on controlled release delivery systems. Controlled release delivery systems play an important role in the development of orally administered drug delivery systems. Controlled release technology provides patients with the required amount of medication over a pre-determined, prolonged period of time. The Company’s product development efforts are based upon three delivery platform technologies: VersaFilm, an Oral Film technology; VersaTab, a Multilayer Tablet technology and AdVersa, a Mucoadhesive Tablet technology.